Function and genetics of dystrophin and dystrophin-related proteins in muscle

被引:885
作者
Blake, DJ [1 ]
Weir, A [1 ]
Newey, SE [1 ]
Davies, KE [1 ]
机构
[1] Univ Oxford, Dept Human Anat & Genet, MRC, Funct Genet Unit, Oxford OX1 3QX, England
关键词
D O I
10.1152/physrev.00028.2001
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The X-linked muscle-wasting disease Duchenne muscular dystrophy is caused by mutations in the gene encoding dystrophin. There is currently no effective treatment for the disease; however, the complex molecular pathology of this disorder is now being unravelled. Dystrophin is located at the muscle sarcolemma in a membrane-spanning protein complex that connects the cytoskeleton to the basal lamina. Mutations in many components of the dystrophin protein complex cause other forms of autosomally inherited muscular dystrophy, indicating the importance of this complex in normal muscle function. Although the precise function of dystrophin is unknown, the lack of protein causes membrane destabilization and the activation of multiple pathophysiological processes, many of which converge on alterations in intracellular calcium handling. Dystrophin is also the prototype of a family of dystrophin-related proteins, many of which are found in muscle. This family includes utrophin and alpha-dystrobrevin, which are involved in the maintenance of the neuromuscular junction architecture and in muscle homeostasis. New insights into the pathophysiology of dystrophic muscle, the identification of compensating proteins, and the discovery of new binding partners are paving the way for novel therapeutic strategies to treat this fatal muscle disease. This review discusses the role of the dystrophin complex and protein family in muscle and describes the physiological processes that are affected in Duchenne muscular dystrophy.
引用
收藏
页码:291 / 329
页数:39
相关论文
共 537 条
  • [1] HUMAN DYSTROPHIN EXPRESSION IN MDX MICE AFTER INTRAMUSCULAR INJECTION OF DNA CONSTRUCTS
    ACSADI, G
    DICKSON, G
    LOVE, DR
    JANI, A
    WALSH, FS
    GURUSINGHE, A
    WOLFF, JA
    DAVIES, KE
    [J]. NATURE, 1991, 352 (6338) : 815 - 818
  • [2] Absence of α-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin
    Adams, ME
    Kramarcy, N
    Krall, SP
    Rossi, SG
    Rotundo, RL
    Sealock, R
    Froehner, SC
    [J]. JOURNAL OF CELL BIOLOGY, 2000, 150 (06) : 1385 - 1397
  • [3] 2 FORMS OF MOUSE SYNTROPHIN, A 58-KD DYSTROPHIN-ASSOCIATED PROTEIN, DIFFER IN PRIMARY STRUCTURE AND TISSUE DISTRIBUTION
    ADAMS, ME
    BUTLER, MH
    DWYER, TM
    PETERS, MF
    MURNANE, AA
    FROEHNER, SC
    [J]. NEURON, 1993, 11 (03) : 531 - 540
  • [4] Adams V, 2001, FRONT BIOSCI-LANDMRK, V6, pD1
  • [5] CLONING OF HUMAN BASIC A1, A DISTINCT 59-KDA DYSTROPHIN-ASSOCIATED PROTEIN ENCODED ON CHROMOSOME 8Q23-24
    AHN, AH
    YOSHIDA, M
    ANDERSON, MS
    FEENER, CA
    SELIG, S
    HAGIWARA, Y
    OZAWA, E
    KUNKEL, LM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) : 4446 - 4450
  • [6] The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives
    Ahn, AH
    Freener, CA
    Gussoni, E
    Yoshida, M
    Ozawa, E
    Kunkel, LM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (05) : 2724 - 2730
  • [7] Calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes
    Alderton, JM
    Steinhardt, RA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (13) : 9452 - 9460
  • [8] Animal models for muscular dystrophy: valuable tools for the development of therapies
    Allamand, V
    Campbell, KP
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (16) : 2459 - 2467
  • [9] Amalfitano Andrea, 1997, P1
  • [10] Utrophin lacks the rod domain actin binding activity of dystrophin
    Amann, KJ
    Guo, AWX
    Ervasti, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (50) : 35375 - 35380